Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment

Samir S. Taneja; William Pierce; Robert Figlin; Arie Belldegrun

doi:10.1016/S0090-4295(99)80108-3

Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment

Samir S. Taneja, William Pierce, Robert Figlin, Arie Belldegrun

Biomedical Engineering

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	911-924
Number of pages	14
Journal	Urology
Volume	45
Issue number	6
DOIs	https://doi.org/10.1016/S0090-4295(99)80108-3
State	Published - Jun 1995

ASJC Scopus subject areas

Urology

Access to Document

10.1016/S0090-4295(99)80108-3

Cite this

@article{a90c6b7c28574803a6861aed362b92e9,

title = "Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment",

author = "Taneja, {Samir S.} and William Pierce and Robert Figlin and Arie Belldegrun",

year = "1995",

month = jun,

doi = "10.1016/S0090-4295(99)80108-3",

language = "English (US)",

volume = "45",

pages = "911--924",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Immunotherapy for renal cell carcinoma

T2 - The era of interleukin-2-based treatment

AU - Taneja, Samir S.

AU - Pierce, William

AU - Figlin, Robert

AU - Belldegrun, Arie

PY - 1995/6

Y1 - 1995/6

UR - http://www.scopus.com/inward/record.url?scp=0028828093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028828093&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(99)80108-3

DO - 10.1016/S0090-4295(99)80108-3

M3 - Review article

C2 - 7771023

AN - SCOPUS:0028828093

SN - 0090-4295

VL - 45

SP - 911

EP - 924

JO - Urology

JF - Urology

IS - 6

ER -

Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this